369 related articles for article (PubMed ID: 21826709)
21. Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells.
Park SH; Doh J; Park SI; Lim JY; Kim SM; Youn JI; Jin HT; Seo SH; Song MY; Sung SY; Kim M; Hwang SJ; Choi JM; Lee SK; Lee HY; Lim CL; Chung YJ; Yang D; Kim HN; Lee ZH; Choi KY; Jeun SS; Sung YC
Gene Ther; 2010 Aug; 17(8):1052-61. PubMed ID: 20485381
[TBL] [Abstract][Full Text] [Related]
22. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
23. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
24. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9.
Ziegler A; Seelig J
Biochemistry; 2011 May; 50(21):4650-64. PubMed ID: 21491915
[TBL] [Abstract][Full Text] [Related]
25. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E).
Martín I; Teixidó M; Giralt E
Chembiochem; 2011 Apr; 12(6):896-903. PubMed ID: 21365733
[TBL] [Abstract][Full Text] [Related]
27. Uptake kinetics of cell-penetrating peptides.
Florén A; Mäger I; Langel U
Methods Mol Biol; 2011; 683():117-28. PubMed ID: 21053126
[TBL] [Abstract][Full Text] [Related]
28. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
Kamide K; Nakakubo H; Uno S; Fukamizu A
Int J Mol Med; 2010 Jan; 25(1):41-51. PubMed ID: 19956900
[TBL] [Abstract][Full Text] [Related]
29. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
30. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
31. Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility.
Jones S; Lukanowska M; Suhorutsenko J; Oxenham S; Barratt C; Publicover S; Copolovici DM; Langel Ü; Howl J
Hum Reprod; 2013 Jul; 28(7):1874-89. PubMed ID: 23585561
[TBL] [Abstract][Full Text] [Related]
32. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
33. A peptide carrier for the delivery of elastin into fibroblast cells.
Nasrollahi SA; Fouladdel S; Taghibiglou C; Azizi E; Farboud ES
Int J Dermatol; 2012 Aug; 51(8):923-9. PubMed ID: 22788807
[TBL] [Abstract][Full Text] [Related]
34. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
[TBL] [Abstract][Full Text] [Related]
35. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
[TBL] [Abstract][Full Text] [Related]
36. Properties of cell penetrating peptides (CPPs).
Kerkis A; Hayashi MA; Yamane T; Kerkis I
IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic applications of cell-penetrating peptides.
Johnson RM; Harrison SD; Maclean D
Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
[TBL] [Abstract][Full Text] [Related]
38. Transduction of cell-penetrating peptides into induced pluripotent stem cells.
Yukawa H; Noguchi H; Nakase I; Miyamoto Y; Oishi K; Hamajima N; Futaki S; Hayashi S
Cell Transplant; 2010; 19(6):901-9. PubMed ID: 20587149
[TBL] [Abstract][Full Text] [Related]
39. Protein delivery with transportans is mediated by caveolae rather than flotillin-dependent pathways.
Säälik P; Padari K; Niinep A; Lorents A; Hansen M; Jokitalo E; Langel U; Pooga M
Bioconjug Chem; 2009 May; 20(5):877-87. PubMed ID: 19348413
[TBL] [Abstract][Full Text] [Related]
40. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
Jobin ML; Alves ID
Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
